Success Story: NIW Victory After RFE! Chinese Postdoc Earns Approval Through Expert Support and Direct Premium Service
Client’s Testimonial:
“That's great news! Thank you for your support throughout this RFE process!”
On July 17th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Fellow in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: China
State of Residence at the Time of Filing: New Jersey
Approval Notice Date: July 17th, 2025
Processing Time: 3 months, 13 days (Premium Processing Requested)
Case Summary:
We are pleased to share the success story of an EB-2 NIW (National Interest Waiver) approval granted to a biomedical science researcher whose work is shaping the future of precision medicine and public health. At the time of filing, the client was engaged in advanced research at a major U.S. medical institution, where she continued to investigate complex diseases by integrating genetic, molecular, and population-level data.
Upon reviewing this case, North America Immigration Law Group (NAILG) determined that the client’s proposed endeavor, characterizing the genetic, molecular, and biological mechanisms underlying complex diseases, was of clear national significance. Her research targets high-impact medical conditions such as neuronal and psychiatric disorders, cancer, and other chronic diseases. By advancing knowledge of these conditions, her work supports early detection, precise diagnostics, and novel therapeutic development, all of which are essential to improving quality of life and reducing healthcare burdens across the United States. The client’s integrative approach, which combines bioinformatics, multi-omics analysis, artificial intelligence, and wet-lab validation, also contributes to public health policies and personalized medical strategies.
With a Ph.D. in pathology and interdisciplinary training in genetics, epidemiology, and bioinformatics, the client has cultivated a robust and impactful research portfolio. She has authored 2 peer-reviewed journal articles, 2 first-authored conference abstracts, and 2 preprints. These contributions have earned a total of 563 citations to date, including publications in top-tier journals. One of her articles has received over 500 citations and ranks among the top 0.1% most-cited papers in biology and biochemistry for its year. This level of recognition highlights the groundbreaking nature and broad influence of her work in the field.
In addition, her research has been directly cited and built upon in other high-impact studies addressing neuroinflammation, cellular signaling, and immunology, further reinforcing her central role in ongoing scientific progress. Through this impactful work, she has significantly advanced the biomedical community’s understanding of disease mechanisms and demonstrated her ability to lead transformative research at the intersection of biology, technology, and medicine.
Despite receiving a Request for Evidence, USCIS approved the EB-2 NIW petition within 3 months of filing under premium processing. This approval underscores the strength of the petition strategy crafted by NAILG and the compelling value of the client’s research to the United States. We are proud to have assisted this exceptional biomedical scientist in securing her NIW approval and look forward to her continued contributions to public health, medical research, and national scientific excellence.